CompuGroup Medical Partners with CVC Capital Partners

CompuGroup Medical SE & Co. KGaA has announced a strategic investment agreement with CVC Capital Partners. CVC intends to proceed with a voluntary public tender offer at EUR 22.00 per share, representing a 51.1% premium compared to the three-month volume-weighted average price. This move is aimed at enhancing CompuGroup Medical’s mission to improve global healthcare through digital innovation.

The founding family Gotthardt, along with related shareholder Dr. Reinhard Koop, will maintain their majority stake in the company. The collaboration is expected to foster long-term growth and innovation, benefiting both patients and healthcare providers worldwide. CompuGroup Medical’s leadership, including CEO Prof. Dr. med. Daniel Gotthardt, welcomes the partnership, seeing it as a catalyst for further expansion.

The offer by CVC will follow regulatory approval and is anticipated to conclude in early 2025. Plans also include taking CompuGroup Medical private after the tender offer is completed. Stakeholders are optimistic about the advantages this strategic alliance will bring, particularly in terms of technological advancements and investment opportunities.